Zinc Therapy in Early Alzheimer’s Disease: Safety and Potential Therapeutic Efficacy by Rosanna Squitti, Amit Pal, Mario Picozza, Abofazl Avan, Mariacarla Ventriglia, Mauro C. Rongioletti, Tjaard Hoogenraad

Get full text

Golgi fragmentation – One of the earliest organelle phenotypes in Alzheimer’s disease neurons by Henriette Haukedal, Giulia I. Corsi, Giulia I. Corsi, Veerendra P. Gadekar, Veerendra P. Gadekar, Nadezhda T. Doncheva, Nadezhda T. Doncheva, Nadezhda T. Doncheva, Shekhar Kedia, Noortje de Haan, Abinaya Chandrasekaran, Pia Jensen, Pernille Schiønning, Sarah Vallin, Frederik Ravnkilde Marlet, Anna Poon, Carlota Pires, Fawzi Khoder Agha, Hans H. Wandall, Susanna Cirera, Anja Hviid Simonsen, Troels Tolstrup Nielsen, Jørgen Erik Nielsen, Poul Hyttel, Ravi Muddashetty, Blanca I. Aldana, Jan Gorodkin, Jan Gorodkin, Deepak Nair, Morten Meyer, Morten Meyer, Martin Røssel Larsen, Kristine Freude

Get full text

Regional desynchronization of microglial activity is associated with cognitive decline in Alzheimer’s disease by Artem Zatcepin, Johannes Gnörich, Boris-Stephan Rauchmann, Laura M. Bartos, Stephan Wagner, Nicolai Franzmeier, Maura Malpetti, Xianyuan Xiang, Yuan Shi, Samira Parhizkar, Maximilian Grosch, Karin Wind-Mark, Sebastian T. Kunte, Leonie Beyer, Carolin Meyer, Desirée Brösamle, Ann-Christin Wendeln, Collins Osei-Sarpong, Steffanie Heindl, Arthur Liesz, Sophia Stoecklein, Gloria Biechele, Anika Finze, Florian Eckenweber, Simon Lindner, Axel Rominger, Peter Bartenstein, Michael Willem, Sabina Tahirovic, Jochen Herms, Katharina Buerger, Mikael Simons, Christian Haass, Rainer Rupprecht, Markus J. Riemenschneider, Nathalie L. Albert, Marc Beyer, Jonas J. Neher, Lars Paeger, Johannes Levin, Günter U. Höglinger, Robert Perneczky, Sibylle I. Ziegler, Matthias Brendel

Get full text

Intranasal Drug Delivery by Nanotechnology: Advances in and Challenges for Alzheimer’s Disease Management by Sayali Dighe, Sunil Jog, Munira Momin, Sujata Sawarkar, Abdelwahab Omri

Get full text

Localized proteomic differences in the choroid plexus of Alzheimer's disease and epilepsy patients by Dominique F. Leitner, Dominique F. Leitner, Dominique F. Leitner, Evgeny Kanshin, Evgeny Kanshin, Arline Faustin, Arline Faustin, Manon Thierry, Manon Thierry, Daniel Friedman, Daniel Friedman, Sasha Devore, Sasha Devore, Beatrix Ueberheide, Beatrix Ueberheide, Beatrix Ueberheide, Orrin Devinsky, Orrin Devinsky, Thomas Wisniewski, Thomas Wisniewski, Thomas Wisniewski, Thomas Wisniewski

Get full text

Neuroprotective role of epigallocatechin-3-gallate, albeginin and melanoxetin in alzheimer's disease by Arif Malik, Mehreen Hassan, Sulayman Waquar, Muhammad Wasim, Anam Naz, Faryal M. Awan, Muhammad T. Khan, Ali I. Khawaja, Sumera Zaib, Jamshed Iqbal, Ayesha Zahid, Marvi Marvi, Javeid Iqbal, Heng Wang, Dong-Qing Wei

Get full text

Inflammatory Cascade in Alzheimer’s Disease Pathogenesis: A Review of Experimental Findings by Jade de Oliveira, Ewa Kucharska, Michelle Lima Garcez, Matheus Scarpatto Rodrigues, João Quevedo, Ines Moreno-Gonzalez, Josiane Budni

Get full text

Asymmetric amyloid deposition in preclinical Alzheimer’s disease: A PET study by Pernille L. Kjeldsen, Peter Parbo, Kim V. Hansen, Joel F.A. Aanerud, Rola Ismail, Peter H. Nissen, Rikke B. Dalby, Malene F. Damholdt, Per Borghammer, David J. Brooks

Get full text

Neutrophil-vascular interactions drive myeloperoxidase accumulation in the brain in Alzheimer’s disease by Leon C. D. Smyth, Helen C. Murray, Madison Hill, Eve van Leeuwen, Blake Highet, Nicholas J. Magon, Mahyar Osanlouy, Sophie N. Mathiesen, Bruce Mockett, Malvindar K. Singh-Bains, Vanessa K. Morris, Andrew N. Clarkson, Maurice A. Curtis, Wickliffe C. Abraham, Stephanie M. Hughes, Richard L. M. Faull, Anthony J. Kettle, Mike Dragunow, Mark B. Hampton

Get full text

Amyloid-β oligomers as a template for secondary amyloidosis in Alzheimer's disease by Marcos J. Guerrero-Muñoz, Diana L. Castillo-Carranza, Shashirekha Krishnamurthy, Adriana A. Paulucci-Holthauzen, Urmi Sengupta, Cristian A. Lasagna-Reeves, Yembur Ahmad, George R. Jackson, Rakez Kayed

Get full text

Pharmacological targeting of MCL-1 promotes mitophagy and improves disease pathologies in an Alzheimer’s disease mouse model by Xufeng Cen, Yanying Chen, Xiaoyan Xu, Ronghai Wu, Fusheng He, Qingwei Zhao, Qiming Sun, Cong Yi, Jie Wu, Ayaz Najafov, Hongguang Xia

Get full text

Synthesis and Characterization of Memantine-Loaded Niosomes for Enhanced Alzheimer’s Disease Targeting by Hasan Turkez, Sena Oner, Ozge Caglar Yıldırım, Mehmet Enes Arslan, Marilisa Pia Dimmito, Çigdem Yuce Kahraman, Lisa Marinelli, Erdal Sonmez, Özlem Kiki, Abdulgani Tatar, Ivana Cacciatore, Antonio Di Stefano, Adil Mardinoglu

Get full text

Targeting Impaired Antimicrobial Immunity in the Brain for the Treatment of Alzheimer’s Disease by Fulop T, Tripathi S, Rodrigues S, Desroches M, Bunt T, Eiser A, Bernier F, Beauregard PB, Barron AE, Khalil A, Plotka A, Hirokawa K, Larbi A, Bocti C, Laurent B, Frost EH, Witkowski JM

“…Dr., Ikerbasque, The Basque Foundation for Science Bilbao, Spain and BCAM - The Basque Center for Applied Mathematics, Mathematical, Computational and Experimental (MCEN) Research Group, Alameda de Mazarredo 14, Bilbao, Bizkaia, Basque-Country, 48009, SpainTel +34 946 567 842Email srodrigues@bcamath.orgAbstract: Alzheimer’s disease (AD) is the most common form of dementia and aging is the most common risk factor for developing the disease. …”
Get full text

Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer's disease and Parkinson's disease by Ganguly G, Chakrabarti S, Chatterjee U, Saso L

“…Gargi Ganguly,1 Sasanka Chakrabarti,2 Uttara Chatterjee,1 Luciano Saso3 1Department of Pathology, Institute of Post Graduate Medical Education and Research, Kolkata, 2Department of Biochemistry, ICARE Institute of Medical Sciences and Research, Haldia, West Bengal, India; 3Department of Physiology and Pharmacology “Vittorio Erspamer”, Sapienza University of Rome, Rome, Italy Abstract: Alzheimer’s disease and Parkinson’s disease are two common neurodegenerative diseases of the elderly people that have devastating effects in terms of morbidity and mortality. …”
Get full text

Comparison Between Burden of Care Partners of Individuals with Alzheimer’s Disease Versus Individuals with Other Chronic Diseases by Murat Demirbas, Julie H. Hahn-Pedersen, Henrik L. Jørgensen

Get full text

Drug Development for Alzheimer’s and Parkinson’s Disease: Where Do We Go Now? by Lisa Sequeira, Sofia Benfeito, Carlos Fernandes, Inês Lima, Joana Peixoto, Catarina Alves, Cláudia Sofia Machado, Alexandra Gaspar, Fernanda Borges, Daniel Chavarria

Get full text

Association of Dopamine Beta-Hydroxylase Polymorphisms with Alzheimer’s Disease, Parkinson’s Disease and Schizophrenia: Evidence Based on Currently Available Loci by Siqi Tang, Bin Yao, Na Li, Shuhuang Lin, Zunnan  Huang

Get full text

Novel Alzheimer risk factor IQ motif containing protein K is abundantly expressed in the brain and is markedly increased in patients with Alzheimer’s disease by Hongjie Wang, Dinesh Devadoss, Madhavan Nair, Hitendra S. Chand, Madepalli K. Lakshmana

Get full text

Kinetics and computational study of butyrylcholinesterase inhibition by methylrosmarinate: relevance to Alzheimer’s disease treatment by Sani Muhammad Uzairu, Yahaya Tijani, Madu Adamu Gadaka, Babagana Modu, Miriam Watafua, Hadiza Ali Ahmad, Umar Abdullahi Zakariya, Aminu Ibrahim, Aliyu Daja, Hassan Zanna, Abdullahi Balarabe Sallau

Get full text

Gram-negative bacteria and their lipopolysaccharides in Alzheimer’s disease: pathologic roles and therapeutic implications by Hyeon soo Kim, Sujin Kim, Soo Jung Shin, Yong Ho Park, Yunkwon Nam, Chae won Kim, Kang won Lee, Sung-Min Kim, In Duk Jung, Hyun Duk Yang, Yeong-Min Park, Minho Moon

Get full text